Conversion Treatment in Unresectable Colorectal Cancer with Synchronous Liver Metastases Using Hepatic Artery Infusion Plus Systemic Chemotherapy

ABSTRACT: Interventions: systymic chemotherapy with XELOX combined with HAI of FUDR and Dex systemic chemotherapy with XELOX alone Primary outcome(s): overall survival time Study Design: Parallel Non-randomized

DISEASE(S): Colorectal Liver Metastases

PROVIDER: 2624924 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR